References
Reddy BS, Rao CV, Rivenson A and Kelloff G: Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14:1493–1497, 1993
Thun MJ, Henley SJ, Patrono C: Nonsteroidal anti–inflammatory drugs as anticancer agents: mechanic, pharmacologic, and clinical issues. J Natl Cancer Inst 94:252–266, 2002
Janne PA, Mayer RJ: Chemoprevention of colorectal cancer. N Engl J Med 342:1960–1968, 2000
Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, Booker SV, Robinson CR, Offerhaus GJA: Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316, 1993
Labayle D, Fischer D, Viehlh P, Drouhin F, Pariente A, Bories C, Duhamel O, Trousset M, Attali P: Sulindac causes regression of rectal polyp in familial adenomatous polyposis. Gastroenterology 101:635–639, 1991
Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM: Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 15:952–954, 1991
Hawk ET, Umar A, Viner JL: Colorectal cancer chemoprevention—An overview of the science. Gastroenterology 126:1423–1447, 2004
Niv Y, Fraser GM: Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 107:854–857, 1994
Thorson AG, Lynch HT, Smyrk TC: Rectal cancer in FAP patient after sulindac. Lancet 15:180, 1994
Matsuhashi N, Nakajima A, Shinohara K, Oka T, Yazaki Y: Rectal cancer after sulindac therapy for a sporadic adenomatous colonic polyp. Am J Gastroenterol 93:2261–2266, 1998
Saito Y, Fujii T, Akasu T, et al.: Development of an aggressive depressed cancer in a case of familial adenomatous polyposis. Endoscopy 34:421–423, 2002
Fujimori T, Satonaka K, Yamamura-Idei Y, et al.: Non-involvement of ras mutations in flat colorectal adenomas and carcinomas. Int J Cancer 57:51–55, 1994
Kudo S, Tamura S, Hirota S, et al.: The problem of de novo colorectal carcinoma. Eur J Cancer 31A:1118–1120, 1995
Owen DA: Flat adenoma, flat carcinoma, and de novo carcinoma of the colon. Cancer 1:3–6, 1996
Hixson LJ, Fennerty MB, Sampliner RE, Garewal HS: Prospective blinded trial of the colonoscopic miss–rate of large colorectal polyps. Gastrointest Endosc 37:125–127, 1991
Rex DK, Cutler CS, Lemmel GT, Rahmani EY, Clark DW, Helper DJ, Lehman GA, Mark DG: Colonoscopic miss rates of adenomas determined by back-to-back colonoscopies. Gastroenterology 112:24–28, 1997
Matsuhashi N, Nakajima A, Fukushima Y, et al.: Effect of Sulinduc sporadic colorectal adenomatous polyps. Gut 40:344–349, 1997
Saito K, Arai K, Mori M: Cyclooxygenase-2 immunoreactivity in depressed-type colorectal adenomas and cancers. Oncol Rep 7:1217–1219, 2000
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaihara, T., Fu, K.I., Sano, Y. et al. Depressed-Type Early Invasive Colon Cancer in a Patient Treated with Cyclooxygenase-2 Inhibitor. Dig Dis Sci 51, 885–888 (2006). https://doi.org/10.1007/s10620-006-9339-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-006-9339-2